Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS   US4643301090

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/30/2015 07/01/2015 07/02/2015 07/06/2015 07/07/2015 Date
57.55(c) 57.16(c) 56.13(c) 55.43(c) 55.36(c) Last
2 946 241 2 138 508 1 521 862 2 563 540 2 259 686 Volume
+2.68% -0.68% -1.80% -1.25% -0.13% Change
More quotes
Financials ($)
Sales 2015 298 M
EBIT 2015 -28,3 M
Net income 2015 -32,0 M
Finance 2015 401 M
Yield 2015 -
Sales 2016 318 M
EBIT 2016 -39,9 M
Net income 2016 -75,4 M
Finance 2016 558 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 20,9x
EV / Sales 2016 19,1x
Capitalization 6 636 M
More Financials
Company
Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform.It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company... 
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
07/06 ISIS PHARMACEUTICALS : Akcea Therapeutics Receives Orphan Drug Designation from ..
07/02 ISIS PHARMACEUTICALS : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
06/30 ISIS PHARMACEUTICALS : Webcast Alert: Corporate Presentation at the 2015 Isis Ph..
06/29 ISIS PHARMACEUTICALS : Promoted to the Large-Cap Russell 1000 Index
06/22 ISIS PHARMACEUTICALS : Reports Data from ISIS-SMN Rx in Children with Spinal Mus..
06/19 ISIS PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of a..
06/16 ISIS PHARMACEUTICALS : to Present a General Corporate Update at its 2015 Annual ..
06/12 ISIS PHARMACEUTICALS' : License Agreement with Bayer for ISIS-FXI Rx Receives Ha..
More news
Sector news : Biotechnology & Medical Research - NEC
07:31a INCYTE : and Vanderbilt University Medical Center Establish Multi-Year Oncology ..
07:30a GENMAB A/S : Announces European Regulatory Submission for Ofatumumab as Maintena..
06:16a SHANGHAI RAAS BLOOD PRODUCTS : Controller Kicks Off Holding Expansion
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
07/06 PREMARKET BIOTECH DIGEST : Arrowhead Initiates Dosing, Vertex Orkambi Approval, ..
07/04 Sector's Smaller Players Show The Way
06/19 Is Biotech Finally In A Bubble?
06/15 Amgen, Regeneron LDL-Lowering Drugs Provide Major Upside Potential To Their S..
06/12 ISIS PHARMACEUTICALS : Another Regeneron (Or Even Better) In The Making?


Comments 
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions